Getting a consensus: Advantages and disadvantages of Sepsis 3 in the context of middle-income settings

Revista Brasileira de Terapia Intensiva

Volumn 28, Issue 4, 2016, Pages 361-365

  Machado, Flavia Ribeiro ^a   De Assunção, Murillo Santucci Cesar ^b   Cavalcanti, Alexandre Biasi ^a   Japiassú, André Miguel ^b   De Azevedo, Luciano Cesar Pontes ^a   Oliveira, Mirella Cristine ^b  

^a Instituto Latino Americano para Estudos Da Sepse   (Brazil)

^b Associação de Medicina Intensiva Brasileira ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS; HUMAN; INTENSIVE CARE; PROCEDURES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CONSENSUS; CRITICAL CARE; HUMANS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 85011048568     PISSN: 0103507X     EISSN: 19824335     Source Type: Journal    
DOI: 10.5935/0103-507X.20160068     Document Type: Review

References (21)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
2. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775-87.
3. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762-74.
4. Erratum in: JAMA. 2016;315(20):2237.
5. Machado FR, Cavalcanti AB, Carrara FS, Bozza FA, Lubarino J, Azevedo LC, et al. Prevalência e mortalidade por sepse grave e choque séptico em unidades de terapia intensiva brasileiras. Rev Bras Terapia Intensiva. 2014;Supl 1:S13.
6. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862-74.
7. Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372(17):1629-38.
8. Churpek MM, Zadravecz FJ, Winslow C, Howell MD, Edelson DP. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients. Am J Respir Crit Care Med. 2015;192(8):958-64.
9. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795-815.
10. Vincent JL, Martin GS, Levy MM. qSOFA does not replace SIRS in the definition of sepsis. Crit Care. 2016;20(1):210.
11. Besen BA, Romano TG, Nassar AP Jr, Taniguchi LU, Azevedo LC, Mendes PV, et al. Sepsis-3 definitions predict ICU mortality in a low-middle-income country. Ann Intensive Care. 2016;6(1):107.
12. Ostermann M, Joannidis M. Acute kidney injury 2016: diagnosis and diagnostic workup. Crit Care. 2016;20(1):299.
13. Neumann JT, Sorensen NA, Schwemer T, Ojeda F, Bourry R, Sciacca V, et al. Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. JAMA Cardiol. 2016;1(4):397-404.
14. Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, Reinhart K, Antonelli M, Pickkers P, Njimi H, Jimenez E, Sakr Y; ICON investigators. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380-6.
15. Giamarellos-Bourboulis EJ, Tsaganos T, Tsangaris I, Lada M, Routsi C, Sinapidis D, Koupetori M, Bristianou M, Adamis G, Mandragos K, Dalekos GN, Kritselis I, Giannikopoulos G, Koutelidakis I, Pavlaki M, Antoniadou E, Vlachogiannis G, Koulouras V, Prekates A, Dimopoulos G, Koutsoukou A, Pnevmatikos I, Ioakeimidou A, Kotanidou A, Orfanos SE, Armaganidis A, Gogos C; Hellenic Sepsis Study Group. Validation of the new sepsis-3 definitions: proposal for improvement in early risk identification. Clin Microbiol Infect. 2016 Nov. 14 pii: S1198-743X(16)30558-4. [Epub ahead of print]
16. Williams JM, Greenslade JH, McKenzie JV, Chu K, Brown AF, Lipman J. SIRS, qSOFA and organ dysfunction: insights from a prospective database of emergency department patients with infection. Chest. 2016 Nov. pii: S0012-3692(16)62359-0. [Epub ahead of print]
17. Surviving Sepsis Campaign. Surviving Sepsis Campaign Responds to Sepsis-3. March 1, 2016. Available in http://www.survivingsepsis.org/ SiteCollectionDocuments/SSC-Statements-Sepsis-Definitions-3-2016.pdf
18. Ferrer R, Artigas A, Levy MM, Blanco J, González-Díaz G, Garnacho-Montero J, Ibáñez J, Palencia E, Quintana M, de la Torre-Prados MV; Edusepsis Study Group. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008;299(19):2294-303.
19. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36(2):222-31.
20. Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40(11):1623-33.
21. Noritomi DT, Ranzani OT, Monteiro MB, Ferreira EM, Santos SR, Leibel F, et al. Implementation of a multifaceted sepsis education program in an emerging country setting: clinical outcomes and cost-effectiveness in a long-term follow-up study. Intensive Care Med. 2014;40(2):182-91.